Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC | JTO Clinical and Research Reports |